Keiretsu Capital

Type

Private equity

Status

Active

Location

Seattle, United States

Total investments

251

Average round size

1M

Portfolio companies

131

Rounds per year

14.76

Lead investments

2

Follow on index

0.48

Exits

12

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHealth DiagnosticsSaaSMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

Keiretsu Capital appeared to be the VC, which was created in 2007. The main department of described VC is located in the Seattle. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Keiretsu Capital, startups are often financed by Keiretsu Forum, Portland Seed Fund, Band of Angels. The meaningful sponsors for the fund in investment in the same round are Keiretsu Forum, Band of Angels, Sand Hill Angels. In the next rounds fund is usually obtained by Puget Sound Venture Club, Keiretsu Forum Northwest, Tech Coast Angels.

The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are SaaS, Internet. Among the most popular portfolio startups of the fund, we may highlight Transform, Inc., Alpin, Perkville. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2016. The fund is constantly included in 7-12 investment rounds annually. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations. When the investment is from Keiretsu Capital the average startup value is 5-10 millions dollars. This Keiretsu Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019.

The fund was created by Matthew Le Merle, Matthew Le Merle, Nathan McDonald, Randy Williams. We also calculated 12 valuable employees in our database.

Show more

Investor highlights

Industry focus
HealthcareFintechClimate tech
Stage focus
Series ASeries B
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
251
Lead investments
2
Exits
12
Rounds per year
14.76
Follow on index
0.48
Investments by industry
  • Health Care (86)
  • Biotechnology (63)
  • Medical (49)
  • Medical Device (45)
  • Software (42)
  • Show 170 more
Investments by region
  • United States (231)
  • India (2)
  • Canada (12)
  • Israel (2)
  • Turkey (1)
  • Show 2 more
Peak activity year
2016
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
13M
Group Appearance index
0.34
Avg. company exit year
10
Avg. multiplicator
0.25
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Atrin Pharmaceuticals 02 Jul 2022 Biotechnology, Medical, Pharmaceutical, Therapeutics, Content Discovery Early Stage Venture United States, Pennsylvania
Clensta 10 Jul 2023 Biotechnology, Health Care, Wellness Early Stage Venture 9M Delhi, New Delhi, India

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.